Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

46.02 -0.41 (-0.88%)

Streaming Delayed Price Updated: 1:10 PM EST, Feb 18, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,205,993
Open	46.22
Bid (Size)	46.01 (200)
Ask (Size)	46.03 (600)
Prev. Close	46.43
Today's Range	45.84 - 46.29
52wk Range	44.62 - 60.12
Shares Outstanding	1,250,690,553
Dividend Yield	4.81%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Moderna’s mRNA Renaissance: Navigating Volatility and the Post-Pandemic Pipeline

February 17, 2026

As of February 17, 2026, Moderna, Inc. (NASDAQ:MRNA) finds itself at a pivotal crossroads in its corporate evolution. Long defined by its meteoric rise during the COVID-19 pandemic, the Cambridge-based...

Via Finterra

Sanofi Tightens Grip on Ocular Therapeutix with Revised Bid as Pivotal SOL-1 Trial Results Loom

February 16, 2026

In a move that could reshape the multi-billion-dollar retinal disease market, French pharmaceutical giant Sanofi (NASDAQ: SNY) has reportedly returned to the negotiating table with a significantly...

Via MarketMinute

Performance

YTD	-4.6%	-4.6%
1 Month	+0.6%	+0.6%
3 Month	-9.2%	-9.2%
6 Month	-8.3%	-8.3%
1 Year	-14.7%	-14.7%

More News

Disc Medicine, Sanofi, Eli Lilly Shares Slip On Reports Of FDA Increasing Review Time For Drugs Granted Priority Review Vouchers ↗

January 15, 2026

Via Stocktwits

Alnylam Pharmaceuticals (ALNY): The RNAi Pioneer’s 2026 Breakout and the Battle for Cardiovascular Dominance

February 12, 2026

Via Finterra

FDA Stuns Moderna with Refusal to Review Flu Vaccine, Sending Shares Tumbling 3.5%

February 12, 2026

Via MarketMinute

This Infrastructure Stock Surged Nearly 40% in One Year -- and One Fund Sold $11 Million in Shares ↗

January 29, 2026

Via The Motley Fool

Lilly Bolsters Immunology Arsenal with $1.2 Billion Acquisition of Ventyx Biosciences

January 28, 2026

Via MarketMinute

Eli Lilly Reinforces Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences

January 27, 2026

Via MarketMinute

Nasdaq, S&P 500 Futures Subdued Ahead Of PMI Data: Why INTC, TSLA, NFLX, VST, MOVE Are On Traders' Radar Today ↗

January 23, 2026

Via Stocktwits

AstraZeneca Signals End of an Era: Formal Move to NYSE Triggers Major Index Rebalancing

January 20, 2026

Via MarketMinute

GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics

January 20, 2026

Via MarketMinute

The Battle for the White Coat: OpenAI and Anthropic Reveal Dueling Healthcare Strategies

January 19, 2026

Via TokenRing AI

Anthropic’s New Specialized Healthcare Tiers: A New Era for AI-Driven Diagnostics and Medical Triage

January 19, 2026

Via TokenRing AI

The mRNA 2.0 Inflection: A Deep Dive into Moderna (MRNA) as it Faces a Critical 2026

January 16, 2026

Via Finterra

Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation

January 15, 2026

Via MarketMinute

Why Did OCUL Stock Jump 13% In Pre-Market Today? ↗

January 15, 2026

Via Stocktwits

Anthropic Launches “Claude for Healthcare”: A Paradigm Shift in Medical AI Integration and HIPAA Security

January 12, 2026

Via TokenRing AI

Cashing In at the Peak: Olema Pharmaceuticals Insiders Sell $8 Million in Stock After 300% Surge

January 09, 2026

Via MarketMinute

MoonLake Immunotherapeutics Surges as FDA "De-Risks" Sonelokimab, Reigniting Multi-Billion Dollar Takeover Speculation

January 09, 2026

Via MarketMinute

BioNTech Finalizes CureVac Acquisition: A Strategic Consolidation Met with Market Skepticism

January 09, 2026

Via MarketMinute

Moderna’s Second Act: A 2026 Deep Dive into the Future of mRNA Therapeutics

January 09, 2026

Via PredictStreet

J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs ↗

January 08, 2026

Via Stocktwits

Trade War 2.0: Markets Braced as Trump’s 2026 Tariff ‘Salvos’ Reshape the Global Supply Chain

January 08, 2026

Via MarketMinute

The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance

January 07, 2026

Via MarketMinute

Moderna’s Second Act: Analyzing the 2026 Pipeline Pivot and Recent Stock Surge

January 07, 2026

Via PredictStreet

Frequently Asked Questions

Is Sanofi - American Depositary Shares publicly traded?

Yes, Sanofi - American Depositary Shares is publicly traded.

What exchange does Sanofi - American Depositary Shares trade on?

Sanofi - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Sanofi - American Depositary Shares?

The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market

What is the current price of Sanofi - American Depositary Shares?

The current price of Sanofi - American Depositary Shares is 46.02

When was Sanofi - American Depositary Shares last traded?

The last trade of Sanofi - American Depositary Shares was at 02/18/26 01:10 PM ET

What is the market capitalization of Sanofi - American Depositary Shares?

The market capitalization of Sanofi - American Depositary Shares is 57.56B

How many shares of Sanofi - American Depositary Shares are outstanding?

Sanofi - American Depositary Shares has 58B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.